ARQT
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. (ARQT) has 17 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jun 18, 2026.
The most active filer is Director Welgus Howard G. with 3 filings. Insiders have net sold $730K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Todd Franklin Watanabe
- Employees:342
- HQ:Westlake Village, CA, US
- IPO:2020-01-31
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$730K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$3.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
LIN SUE-JEANFirst filing | Director | Sale | 4,946 | $121K | Jun 18 | SEC ↗ |
| Director | Sale | 4,096 | $100K | Jun 18 | SEC ↗ | |
| Director | Sale | 635 | $16K | Jun 18 | SEC ↗ | |
| SVP Chief Financial Officer | Sale | 435 | $9K | May 13 | SEC ↗ | |
| See Remarks | Sale | 222 | $5K | May 13 | SEC ↗ | |
Matsuda MasaruFirst filing | See Remarks | Sale | 8,256 | $192K | May 6 | SEC ↗ |
Burnett PatrickFirst filing | See Remarks | Sale | 684 | $16K | May 6 | SEC ↗ |
Vairavan LathaFirst filing | SVP Chief Financial Officer | Sale | 1,341 | $32K | May 6 | SEC ↗ |
Watanabe ToddFirst filing | See Remarks | Sale | 3,172 | $75K | May 6 | SEC ↗ |
Welgus Howard G.First filing | Director | Sale | 7,144 | $164K | May 6 | SEC ↗ |
Congress trading ARQT
See timeline →- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-29
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
Arcutis Biotherapeutics, Inc. is in the Healthcare sector.